Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Headwaters Capital's investment thesis on Bio-Techne ($TECH) — Q2 2025 | Buyside Digest

$TECHNASDAQBio-Techne

BULL

Headwaters Capital—TECH

Fund Letter

Q2 2025

Published July 10, 2025

$72.43USD

-0.0% vs last month

$54.14Pitched

+33.8% since pitch

Market Cap$11.2B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

In Q2 2025, Headwaters Capital gained +7.5% gross (+7.3% net) compared to a +8.5% gain for the Russell Mid Cap Index. The manager outlines...

— Christopher Godfrey

BSD Research Exclusive

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

Other investors who've written on Bio-Techne

No other institutional pitches found for this ticker yet.